Skip to main content
SpringerLink
Log in

Bevacizumab/capecitabine/oxaliplatin

Nausea and diarrhoea: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hisatsune Y, et al. A patient who showed a pathologically complete response after undergoing treatment with XELOX plus bevacizumab for synchronous liver metastasis of grade H2 from sigmoid colon cancer. Journal of Gastrointestinal Oncology 4: E5-E10, No. 2, Jun 2013. Available from: URL: http://dx.doi.org/10.3978/j.issn.2078-6891.2012.060 - Japan

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevacizumab/capecitabine/oxaliplatin. Reactions Weekly 1455, 9 (2013). https://doi.org/10.1007/s40278-013-3591-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-3591-y

Search

Navigation